MedPath

PHENOBARBITAL

PHENOBARBITAL TABLETS, USP C-IVRx only

Approved
Approval ID

7e6853a4-478d-40e3-b041-4cff02a74c8c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 16, 2023

Manufacturers
FDA

QUAGEN PHARMACEUTICALS LLC

DUNS: 073645339

Products 4

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

PHENOBARBITAL

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70752-161
Product Classification
G
Generic Name
PHENOBARBITAL
Product Specifications
Route of AdministrationORAL
Effective DateFebruary 16, 2023
FDA Product Classification

INGREDIENTS (6)

PHENOBARBITALActive
Quantity: 16.2 mg in 1 1
Code: YQE403BP4D
Classification: ACTIB
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE AInactive
Code: H8AV0SQX4D
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

PHENOBARBITAL

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70752-164
Product Classification
G
Generic Name
PHENOBARBITAL
Product Specifications
Route of AdministrationORAL
Effective DateFebruary 16, 2023
FDA Product Classification

INGREDIENTS (6)

PHENOBARBITALActive
Quantity: 97.2 mg in 1 1
Code: YQE403BP4D
Classification: ACTIB
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE AInactive
Code: H8AV0SQX4D
Classification: IACT

PHENOBARBITAL

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70752-163
Product Classification
G
Generic Name
PHENOBARBITAL
Product Specifications
Route of AdministrationORAL
Effective DateFebruary 16, 2023
FDA Product Classification

INGREDIENTS (6)

PHENOBARBITALActive
Quantity: 64.8 mg in 1 1
Code: YQE403BP4D
Classification: ACTIB
SODIUM STARCH GLYCOLATE TYPE AInactive
Code: H8AV0SQX4D
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT

PHENOBARBITAL

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70752-162
Product Classification
G
Generic Name
PHENOBARBITAL
Product Specifications
Route of AdministrationORAL
Effective DateFebruary 16, 2023
FDA Product Classification

INGREDIENTS (6)

PHENOBARBITALActive
Quantity: 32.4 mg in 1 1
Code: YQE403BP4D
Classification: ACTIB
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE AInactive
Code: H8AV0SQX4D
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PHENOBARBITAL - FDA Drug Approval Details